Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorOHSU Knight Cancer Institute

About this trial

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Eligibility criteria

Qualifiers

AIM 1: Suspected lung cancer

AIM 1: English fluency

AIM 1: > 6-month life expectancy

AIM 1: Score of ≥ 3 on the cognitive impairment screener

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Best Practice
  • Health Promotion and Education
  • Questionnaire Administration

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

OHSU Knight Cancer Institute

Lead sponsor

Oregon Health and Science University

Collaborator

American Cancer Society, Inc.

Collaborator